explore -WSS

explore

author：focus 2025-09-27 12:22:56 - browse：61

Slayman with (left to right) Dr. Leo Riella, Medical Director of Kidney Transplantation, Dr. Nahel Elias, Interim Chief, Division of Transplant Surgery, his partner, Faren, and Dr. Tatsuo Kawai, Director, Legorreta Center for Clinical Transplant Tolerance. -- HEALTH coverage from STAT — Rick Slayman, holding hands with his partner, Faren, poses with members of his Massachusetts General Hospital medical team before being going home last month. Michelle Rose/Massachusetts General Hospital

Rick Slayman, the first man to receive a kidney transplant from a genetically engineered pig, has died, according to a statement from his family and Massachusetts General Hospital, where he underwent the historic operation in March.

“Our family is deeply saddened about the sudden passing of our beloved Rick but take great comfort knowing he inspired so many,” his family said in the statement released Saturday evening.

The hospital did not say how or when Slayman died. A spokesperson declined to provide further information, citing “privacy issues.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

WSS

The Harvard botanist who searched for psychedelics in the Amazon

NIH study of ME/CFS points to clear biological hallmarks

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Alabama frozen embryo ruling has major implications for IVF clinics

Tuberculosis patients need more than just free medication

Why palliative psychiatry is worth discussing

entertainment

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

explore

DIEP, the 'gold standard' of breast reconstruction, is under threat

Paxlovid rebound happens. Why and to whom are still a mystery

23andMe had bad news about my health. I wish a person had delivered it

With heat waves through August, officials warn of health risks

Cancer drug shortages should be causing more outrage

In utero gene editing: an explainer

Walensky prepares to leave CDC — and Congress — behind

Medicare inequities exacerbate Puerto Rico’s health disparities

The high cost of giving birth even with insurance

The Harvard botanist who searched for psychedelics in the Amazon

entertainment

PBM reform efforts get punted in Congress

A new nitrogen execution bill also undermines medical licensing

It was time to plan for my old age. If only I could stop crying

Feed a cold, starve a fever? Here’s what science says

St. Louis police protesters begin picking up checks in $4.9 million settlement

Medicare inequities exacerbate Puerto Rico’s health disparities

entertainment

leisure time

focus

hotspot